SAAP-02 - IPS workshop organised in collaboration with USP*

Meeting room 1.43-1.44
Organised by FIPs Industrial Pharmacy Section (IPS)

Target audience: Industrial Pharmacists, scientists and leaders in manufacturing environments

Chair(s)

Mr Sola Solarin, President FIP Industrial Pharmacy Section, Nigeria

Introduction

INNOVATIONS IN PHARMACEUTICAL MANUFACTURING TECHNOLOGIES: WHAT ARE THE IMPLICATIONS FOR GMP?

Navigating the pharmaceutical industry’s intricate ecosystem alongside digital acceleration and new modalities such as cell therapy and advanced manufacturing technologies, can be quite complex. However, such complexity presents opportunities to develop skills, implement successful technologies and improve competitiveness. Let us come together to engage in robust topics and discussions which can benefit the industry and the patients we serve.

The IPS GMP Workshop organised in collaboration with USP, is packed with knowledgeable and globally respected speakers. The workshop organised in collaboration with USP, will attract regulators, pharmacists, scientific and industry professionals to gather with an intent to learn, share experiences and network.

 

Programme

09:00 – 09:30

Keynote address – Advanced manufacturing technologies: Innovative technologies in the pharmaceutical industry: Where to from here?
Mr Dennis Hall, VP Advanced Manufacturing Technologies, USP
09:30 – 10:00

Robotics and automation
Mr Richard Denk, SKAN AG Switzerland, ISPE European Affiliate Council Chair 2024
10:00 – 10:05 Q&A
10:05 – 10:35

Promoting drug access through GMP: case study on Emerging Markets from BRICS and Latin America
Mr Igor Linhares de Castro, MEDIFARMA Corporation
10:35 – 10:40 Q&A
10:40 – 11:00 Tea break and networking
11:00 – 11:30

Laboratory automation: Smart quality control and implementation
Mr Sekhar Surabhi, CEO Caliber
11:30 – 12:00

Tech innovation through building drug substance capacity: Oral cholera vaccine project
Mr Ebrahim Mohamed, Biovac
12:00 – 12:30

Bringing AI in the world of C&Q
Mr Pierre Winnepenninckx, CEO of No Deviation
12:30 – 13:00

Artificial Intelligence and its impact on GMP of the future
Prof. Ogbonna Okorie (Immediate past Dean), Faculty of Pharmaceutical Sciences, University Of Port Harcourt, Nigeria
13:00 – 13:15 Panel discussion with speakers

13:15 – 14:00

 Lunch break
 

Review of challenges for implementation of Q12 and Q13 in Africa
14:00 – 14:30

GMP challenges in developing countries
Mr Deon Poovan, Inspectorate and Regulatory Compliance, South African Health Products Regulatory Authority (SAHPRA)
14:30 – 15:00

Review of challenges for implementation of Q12 and Q13 in Africa
Dr Jude Nwokike, Vice President & Director, Promoting the Quality of Medicines Plus (PQM+) Program, USP)
15:00 – 15:30

Collaborative approach with South African Health Products Regulatory Authority
Mr Devendren Subbaramoney, Biovac
15:30 – 16:00

Innovation in cell and gene therapy and role of standards
Dr Fouad Atouf, Snr. Vice President, Global Biologics, USP
16:00 – 16:30  Closing panel discussion: GMP of the future with above speakers
16:30 – 16:45 Closing by the IPS President

Registration

The session is accessible with pre-registration only via the regular congress registration. Costs are EUR 130 / ZAR 2,600 for FIP members and EUR 190 / ZAR 3,800 for non-FIP members.